Schedule 13D ownership disclosure

N/A

Common Stock, par value $0.001 per share · CUSIP: 282559103

Event date: 2025-02-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.Reported CIK 0001346824

    Shares: 20,013,733.00 · Class: 13.7%

  • Peter KolchinskyReported CIK 0001384859

    Shares: 20,013,733.00 · Class: 13.7%

  • Rajeev ShahReported CIK 0001619841

    Shares: 20,013,733.00 · Class: 13.7%

  • RA Capital Healthcare Fund, L.P.Reported CIK 0001315082

    Shares: 19,554,319.00 · Class: 13.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-006299
Form type
SCHEDULE 13D/A
Filer
89bio, Inc.
CIK
CIK 1785173
Filed
Mar 03, 2025
Reporting period
Feb 27, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub